Oldest pages

From OncoWiki
Jump to: navigation, search

Showing below up to 50 results in range #1 to #50.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. 5-FU + Cisplatin + Vinblastine + RT + Surgery‏‎ (02:17, 7 February 2012)
  2. 5-FU + Cisplatin‏‎ (02:17, 7 February 2012)
  3. 5-FU + Cisplatin + Docetaxel‏‎ (02:17, 7 February 2012)
  4. 5-FU + Cisplatin + RT‏‎ (02:17, 7 February 2012)
  5. 5-FU + Cisplatin + RT + Surgery‏‎ (02:17, 7 February 2012)
  6. Acute Lymphoblastic Leukemia, Pediatric‏‎ (02:17, 7 February 2012)
  7. ABVD‏‎ (02:17, 7 February 2012)
  8. 5-FU + LV‏‎ (02:17, 7 February 2012)
  9. AC‏‎ (02:17, 7 February 2012)
  10. Adriamycin + Cisplatin‏‎ (02:17, 7 February 2012)
  11. 5-FU + LV + Bevacizumab‏‎ (02:17, 7 February 2012)
  12. AD‏‎ (02:17, 7 February 2012)
  13. Adriamycin + Cisplatin + Paclitaxel‏‎ (02:17, 7 February 2012)
  14. 5-FU + LV + Irinotecan‏‎ (02:17, 7 February 2012)
  15. ADE‏‎ (02:17, 7 February 2012)
  16. Alemtuzumab‏‎ (02:17, 7 February 2012)
  17. 5-FU + LV + Mitomycin + Dipyridamole‏‎ (02:17, 7 February 2012)
  18. ADOC‏‎ (02:17, 7 February 2012)
  19. 5-FU + LV + RT‏‎ (02:17, 7 February 2012)
  20. AI‏‎ (02:17, 7 February 2012)
  21. 5-FU + RT‏‎ (02:17, 7 February 2012)
  22. AIDA-PETHEMA Group‏‎ (02:17, 7 February 2012)
  23. 5-FU MitomycinC Radiation Therapy EORTC Regimen‏‎ (02:17, 7 February 2012)
  24. ASHAP‏‎ (02:17, 7 February 2012)
  25. 5-FU MitomycinC Radiation Therapy Wayne State Regimen‏‎ (02:17, 7 February 2012)
  26. A-C-T‏‎ (02:17, 7 February 2012)
  27. Acute Lymphoblastic Leukemia, Adult‏‎ (02:17, 7 February 2012)
  28. ABDIC‏‎ (02:17, 7 February 2012)
  29. BEP‏‎ (02:17, 7 February 2012)
  30. Bladder Cancer‏‎ (02:17, 7 February 2012)
  31. BFM- 95 (German Protocol)‏‎ (02:17, 7 February 2012)
  32. Bonn protocol‏‎ (02:17, 7 February 2012)
  33. BFM B-Cell‏‎ (02:17, 7 February 2012)
  34. Bortezomib‏‎ (02:17, 7 February 2012)
  35. Bendamustine‏‎ (02:17, 7 February 2012)
  36. Brain Tumors Adult‏‎ (02:17, 7 February 2012)
  37. Bendamustine + Rituximab‏‎ (02:17, 7 February 2012)
  38. Breast Cancer‏‎ (02:17, 7 February 2012)
  39. Alemtuzumab + Fludarabine‏‎ (02:17, 7 February 2012)
  40. Bevacizumab‏‎ (02:17, 7 February 2012)
  41. CAF‏‎ (02:17, 7 February 2012)
  42. Amrubicin‏‎ (02:17, 7 February 2012)
  43. Bevacizumab + Erlotinib‏‎ (02:17, 7 February 2012)
  44. CALGB 8811‏‎ (02:17, 7 February 2012)
  45. Anal Carcinoma‏‎ (02:17, 7 February 2012)
  46. Bevacizumab + IFN‏‎ (02:17, 7 February 2012)
  47. Arsenic Trioxide for APML, new cases‏‎ (02:17, 7 February 2012)
  48. BiRD‏‎ (02:17, 7 February 2012)
  49. Arsenic Trioxide for relapsed APML‏‎ (02:17, 7 February 2012)
  50. Bicalutamide‏‎ (02:17, 7 February 2012)

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)